Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank29
Studio
Year-over-Year Change

Return on equity

Percentile
P29
Within normal range
vs 2Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-219.69%+29.6%
2024-311.87%-200.5%
2023310.45%+193.1%
2022-333.42%-356.8%
2021-73.00%-165.0%
2020-27.55%+82.3%
2019-155.56%-55.8%
2018-99.83%+20.8%
2017-126.11%-176.3%
2016-45.65%-